Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies
Takao Arimori, Emiko Mihara, Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K. Kaneko, Junichi Takagi, Yukinari Kato
Topics & Concepts
AntibodyCancerCancer cellTrastuzumabMonoclonal antibodyCancer researchFlow cytometryChemistryEpidermal growth factor receptorBiologyMolecular biologyBreast cancerImmunologyGeneticsMonoclonal and Polyclonal Antibodies ResearchHER2/EGFR in Cancer ResearchGlycosylation and Glycoproteins Research